| World malaria report 2022 World Health Organization World Health Organization, 2022 | 13957* | 2022 |
| Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study L Beaugerie, N Brousse, AM Bouvier, JF Colombel, M Lémann, J Cosnes, ... The Lancet 374 (9701), 1617-1625, 2009 | 1216 | 2009 |
| Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection O Hermine, F Lefrère, JP Bronowicki, X Mariette, K Jondeau, ... New England Journal of Medicine 347 (2), 89-94, 2002 | 979 | 2002 |
| Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria P Valent, C Akin, L Escribano, M Födinger, K Hartmann, K Brockow, ... European journal of clinical investigation 37 (6), 435-453, 2007 | 895 | 2007 |
| Effect of tocilizumab vs usual care in adults hospitalized with COVID-19 and moderate or severe pneumonia: a randomized clinical trial O Hermine, X Mariette, PL Tharaux, M Resche-Rigon, R Porcher, ... JAMA internal medicine 181 (1), 32-40, 2021 | 884 | 2021 |
| Gene therapy in patients with transfusion-dependent β-thalassemia AA Thompson, MC Walters, J Kwiatkowski, JEJ Rasko, JA Ribeil, ... New England Journal of Medicine 378 (16), 1479-1493, 2018 | 691 | 2018 |
| Transforming growth factor β1, in the presence of granulocyte/macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood … F Geissmann, C Prost, JP Monnet, M Dy, N Brousse, O Hermine The Journal of experimental medicine 187 (6), 961-966, 1998 | 643 | 1998 |
| Treatment of older patients with mantle-cell lymphoma HC Kluin-Nelemans, E Hoster, O Hermine, J Walewski, M Trneny, ... New England Journal of Medicine 367 (6), 520-531, 2012 | 629 | 2012 |
| Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA) O Hermine, C Haioun, E Lepage, MF d'Agay, J Briere, C Lavignac, G Fillet, ... | 616 | 1996 |
| Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting K Tsukasaki, O Hermine, A Bazarbachi, L Ratner, JC Ramos, ... Journal of Clinical Oncology 27 (3), 453, 2009 | 591 | 2009 |
| High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis A Jaccard, P Moreau, V Leblond, X Leleu, L Benboubker, O Hermine, ... New England Journal of Medicine 357 (11), 1083-1093, 2007 | 585 | 2007 |
| Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation F Suarez, O Lortholary, O Hermine, M Lecuit Blood 107 (8), 3034-3044, 2006 | 543 | 2006 |
| TGF-β1 prevents the noncognate maturation of human dendritic Langerhans cells F Geissmann, P Revy, A Regnault, Y Lepelletier, M Dy, N Brousse, ... The Journal of Immunology 162 (8), 4567-4575, 1999 | 517 | 1999 |
| Caspase activation is required for terminal erythroid differentiation Y Zermati, C Garrido, S Amsellem, S Fishelson, D Bouscary, F Valensi, ... The Journal of experimental medicine 193 (2), 247-254, 2001 | 510 | 2001 |
| Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study S Choquet, V Leblond, R Herbrecht, G Socié, AM Stoppa, ... Blood 107 (8), 3053-3057, 2006 | 493 | 2006 |
| Efficacy and safety of midostaurin in advanced systemic mastocytosis J Gotlib, HC Kluin-Nelemans, TI George, C Akin, K Sotlar, O Hermine, ... New England Journal of Medicine 374 (26), 2530-2541, 2016 | 487 | 2016 |
| CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans S Weller, A Faili, C Garcia, MC Braun, F Le Deist, G de Saint Basile, ... Proceedings of the National Academy of Sciences 98 (3), 1166-1170, 2001 | 472 | 2001 |
| Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis P Domingo, I Mur, GM Mateo, M del Mar Gutierrez, V Pomar, N de Benito, ... Jama 326 (6), 499-518, 2021 | 470 | 2021 |
| ALS clinical trials review: 20 years of failure. Are we any closer to registering a new treatment? D Petrov, C Mansfield, A Moussy, O Hermine Frontiers in aging neuroscience 9, 68, 2017 | 460 | 2017 |
| Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML) N Boissel, H Leroy, B Brethon, N Philippe, S De Botton, A Auvrignon, ... Leukemia 20 (6), 965-970, 2006 | 453 | 2006 |
